Go Pro
OTCMKTS:VTRLY

Vitrolife AB (publ) (VTRLY) Stock Price, News & Analysis

Vitrolife AB (publ) logo
$9.50 0.00 (0.00%)
As of 08/4/2026

About Vitrolife AB (publ) Stock (OTCMKTS:VTRLY)

Advanced

Key Stats

Today's Range
$9.50
$9.50
50-Day Range
$9.50
$11.37
52-Week Range
$9.50
$18.55
Volume
25 shs
Average Volume
1,643 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Vitrolife AB (publ) is a Sweden‐based life science company specializing in products and systems for in vitro fertilization (IVF) and assisted reproductive technologies. Founded in 1994 and headquartered in Gothenburg, the company develops, manufactures and markets a comprehensive portfolio of consumables, culture media and instruments that support the entire IVF process, from gamete handling to embryo culture and cryopreservation.

The company’s product range includes embryo culture media, blastocyst media, vitrification solutions and pipetting tools designed to optimize laboratory workflows and improve outcomes for fertility clinics and patients. Vitrolife also offers advanced incubation systems with integrated time‐lapse imaging technology, enabling embryologists to monitor embryo development in real time and make more informed selection decisions.

Vitrolife serves a global customer base through its own sales organizations and a network of distributors across Europe, North America, Asia and other key markets. The company operates subsidiaries in several regions to provide localized technical support, training and regulatory expertise. Its geographic footprint and robust supply chain logistics are designed to ensure consistent product availability and adherence to international quality standards.

With a commitment to research and development, Vitrolife invests in innovation and collaborates with academic and clinical partners to advance reproductive medicine. The company’s management team comprises professionals with deep expertise in biotechnology and medical device commercialization, guiding Vitrolife’s strategy to expand its presence in the rapidly evolving field of fertility treatment.

AI Generated. May Contain Errors.

Receive VTRLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vitrolife AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VTRLY Stock News Headlines

ALT SL: New Patent Reveals Elon Musk’s Next Breakthrough: M.A.G.I.
Jeff Brown and Marc Chaikin - two investors who spotted Nvidia a decade ago - are now pointing to Elon Musk's latest AI patent as the catalyst behind their next major call. They say a market pattern with a 100% historical track record is converging with this new breakthrough by end of month. The last time conditions aligned like this, investors had the chance to turn $10,000 into as much as $350,000 in roughly 12 months. Brown and Chaikin have released the full details for investors who want to get ahead of it.tc pixel
See More Headlines

VTRLY Stock Analysis - Frequently Asked Questions

Vitrolife AB (publ)'s stock was trading at $15.0650 at the start of the year. Since then, VTRLY stock has decreased by 36.9% and is now trading at $9.50.

Shares of VTRLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:VTRLY
CIK
N/A
Fax
N/A
Employees
1,132
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (OTCMKTS:VTRLY) was last updated on 8/6/2026 by MarketBeat.com Staff.
From Our Partners